NCT07829471
- Conditions
- Clinical Outcomes, Neoadjuvant Therapy, Pancreatic Adenocarcinoma, +2 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying ePRO. Study availability and eligibility vary by location and protocol.
NCT07829471